Zobrazeno 1 - 10
of 18
pro vyhledávání: '"P J, Cagnoni"'
Autor:
Elmer A Fernández, Joaquin P Merlo, Yamil D Mahmoud, Florencia Veigas, Marco A Scheidegger, Alejandro J Cagnoni, Gabriel A Rabinovich, Karina V Marino
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/5ba236a9fa294710bd8e4a4e6f29d5e1
Autor:
Julia Rubione, Paula S. Pérez, Alejandro Czernikier, Gabriel A. Duette, Federico Pehuen Pereyra Gerber, Jimena Salido, Martina P. Fabiano, Yanina Ghiglione, Gabriela Turk, Natalia Laufer, Alejandro J. Cagnoni, Juan M. Pérez Sáez, Joaquín P. Merlo, Carla Pascuale, Juan C. Stupirski, Omar Sued, Manuel Varas-Godoy, Sharon R. Lewin, Karina V. Mariño, Gabriel A. Rabinovich, Matías Ostrowski
Publikováno v:
mBio, Vol 13, Iss 4 (2022)
ABSTRACT Combined Antiretroviral therapy (cART) suppresses HIV replication but fails to eradicate the virus, which persists in a small pool of long-lived latently infected cells. Immune activation and residual inflammation during cART are considered
Externí odkaz:
https://doaj.org/article/e9d71457b2f84f5da38d7bf12b2e8d3e
Autor:
María Emilia Cano, Rosalía Agusti, Alejandro J. Cagnoni, María Florencia Tesoriero, José Kovensky, María Laura Uhrig, Rosa M. de Lederkremer
Publikováno v:
Beilstein Journal of Organic Chemistry, Vol 10, Iss 1, Pp 3073-3086 (2014)
In this work we describe the synthesis of mono- and divalent β-N- and β-S-galactopyranosides and related lactosides built on sugar scaffolds and their evaluation as substrates and inhibitors of the Trypanosoma cruzi trans-sialidase (TcTS). This enz
Externí odkaz:
https://doaj.org/article/382ed49104c842c2ab0e4a7a3ec35208
Autor:
Deanna A. Sutton, Josep Guarro, Michael G. Rinaldi, Nancy E. Madinger, R. Veve, Elizabeth H. Thompson, P. J. Cagnoni, K. Moultney, Michelle A. Barron
We report the first two cases of invasive human mycoses caused by the phaeoid ascomycete, Chaetomium perlucidum , and review the English literature regarding invasive Chaetomium infections. Fatal disseminated disease involving the brain, heart, lungs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf88a91e4054abbc9216fdbdf9d5b25d
https://europepmc.org/articles/PMC262481/
https://europepmc.org/articles/PMC262481/
Autor:
P. Pouillart, S. T. Sonis, H. G. Derigs, F. LeVeque, C. H. Brandts, M. C. Foncuberta, Eckhard Thiel, R. Emmons, K. Fields, J. Fay, P. J. Cagnoni, H. Schrezenmeier, R. Mandanas, Elizabeth C. Reed
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 24(4)
Transforming growth factor (TGF)-beta3 has been hypothesized to prevent or alleviate oral mucositis (OM) in cancer patients receiving high-dose chemotherapy (CT). Two double-blind, placebo-controlled, multicenter, phase II studies of TGF-beta3 were i
Autor:
Y, Nieto, P J, Cagnoni, E J, Shpall, X, Xu, J, Murphy, J, Vredenburgh, N J, Chao, S I, Bearman, R B, Jones
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(11)
High-dose chemotherapy (HDCT) is currently under evaluation for high-risk primary breast cancer (HRPBC), defined by extensive axillary nodal involvement or inflammatory breast carcinoma. Phase II studies of HDCT for HRPBC show that 30-40% of patients
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(7)
The purpose of this study was to assess the efficacy of high-dose chemotherapy (HDC) with autologous stem cell transplant in stage IV breast cancer patients with minimal metastases. Eligible patients had (a) disease that could be resected en bloc and
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(4)
Our objective was to assess whether the total area under the curve (AUC) of high-dose cyclophosphamide (CPA), combined with cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea, could be predicted from its AUC on the first day of treatment. We reviewed
Autor:
Y, Nieto, P J, Cagnoni, S I, Bearman, E J, Shpall, S, Matthes, T, DeBoom, A, Barón, R B, Jones
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(3)
The purpose of this study was to describe acute encephalopathy as a new toxicity associated with paclitaxel, when it is delivered at high doses (or =600 mg/m2) with stem cell support. A total of 129 patients, included in clinical trials of paclitaxel
Publikováno v:
Cancer treatment and research. 95